Sharma Mani 4

What Happened Sharma Mani, SVP, Group Controller and Head of Global Finance Services at AstraZeneca plc, sold 11,893 ordinary shares in an open-market transaction on May 20, 2026. The shares were sold at an effective price of $185.78 per share (converted from GBP139.35), for a total proceeds of $2,209,482. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-05-20 (reported on Form 4 filed 2026-05-22; filing was timely)
• Transaction type: Open-market sale
• Shares sold: 11,893
• Price per share: $185.78 (GBP139.35 converted using GBP1 = $1.3332 on May 15, 2026)
• Total proceeds: $2,209,482
• Shares owned after transaction: Not specified in the filing
• Footnote: Price conversion from British pounds to U.S. dollars per Board of Governors of the Federal Reserve System
• No 10b5-1 plan, tax withholding, or option exercise was indicated in this filing

Context Sales by officers are often routine (e.g., diversification or liquidity needs) and do not by themselves indicate a change in company outlook. Because this filing shows a straightforward open-market sale with conversion from GBP to USD, there are no derivative or complex transaction mechanics to explain.